StreetAlpha.app
Home › Stocks › HIND

Vyome Holdings, Inc (HIND)

$1.20
▼ −17.24%
LAST CLOSE · NOV 20

Vyome develops treatments for rare and immune inflammatory diseases and sells antifungal products in India. It last closed at $1.20 on Nov 20, down 17.24% on the day. For the quarter ended Sep 2026, HIND reported EPS of -$0.13 on revenue of $57,998, with revenue up 67.5% from a year ago. Over its last 8 reports the stock moved an average of 4.2% the session after earnings.

AI Auto Pilots
Is HIND in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold HIND.

Key Stats

Last 12 months
Results
Revenue
$153K
−55.6% vs a year ago
Net income
−$3.8M
−2455.6% margin
Gross margin
50.4%
$77K gross profit
Operating margin
−2853.6%
−$4.4M operating income
Valuation
Market cap
$8.4M
7.0M shares
P/E
–
Price to sales
55.0
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$7.0M
At Sep 30
Shares outstanding
7.0M
At Nov 9
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $13.6M$13.6MFY2021FY2022: $11.2M$11.2MFY2022FY2023: $8.7M$8.7MFY2023FY2024: $257K$257KFY2024FY2025: $320K$320KFY2025

From HIND's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 12). Last 12 months adds up the four latest quarters.

Last report
Aug 25
2026 · next date not set yet
Reported EPS
-$0.13
Quarter ended Sep 2026
Year ago EPS
-$3.06
Same quarter last year
Revenue
$57,998
+67.5% vs a year ago
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Dec 2024: -$3045.68Dec '24Mar 2025: -$761.59Mar '25Jun 2025: -$799.90Jun '25Sep 2025: -$3.06Sep '25Dec 2025: $4.96Dec '25Mar 2026: -$0.15Mar '26Jun 2026: -$0.10Jun '26Sep 2026: -$0.13Sep '26Latest -$0.13
Revenue by quarter
Dec 2024: $61,428Dec '24Mar 2025: $198,581Mar '25Jun 2025: $49,954Jun '25Sep 2025: $34,627Sep '25Dec 2025: $36,551Dec '25Mar 2026: $31,591Mar '26Jun 2026: $26,955Jun '26Sep 2026: $57,998Sep '26Latest $57,998
How HIND moved after its last 8 reports
Average move the session after a report ±4.2%
Aug 25, 2026After the close−3.1%
May 29, 2026Time not announced−0.4%
Nov 19, 2025After the close+3.5%
Nov 14, 2024After the close+1.4%
Aug 14, 2024After the close−1.0%
May 20, 2024After the close−12.2%
Apr 4, 2024Time not announced−2.7%
Nov 8, 2023After the close−9.2%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on HINDStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on HIND
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on HIND

Technical Analysis

HIND · as of the Nov 20 close · updated each morning
Downtrend, oversold

The stock is 35% below its 20 day and 52% below its 50 day average. It is 80% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 19), oversold. The nearest support is the Pivot S1 at $1.12, and the nearest resistance the Pivot at $1.28.

Short trendBearish
Long trendBearish
MomentumWeak
StretchOversold
VolatilityNormal, 9.1%/day
Key levels
$5.8852 week high+390.0%
$2.17200 day average+80.8%
$2.00100 day average+66.7%
$1.8250 day average+51.7%
$1.72Swing high (Nov 11)+43.3%
$1.6220 day average+35.0%
$1.35Pivot R1+12.5%
$1.28Pivot+6.7%
$1.2052 week low+0.0%
$1.20Last close
$1.12Pivot S1−6.7%
Indicators
RSI (14)18.62Oversold below 30Oversold
MACD-0.13Below its signal lineBearish
Stochastic1.0Near the bottom of its rangeOversold
ADX (14)13.6No clear trend
Williams %R-100.0Oversold below −80, overbought above −20Oversold
CCI (20)-225.4Oversold below −100, overbought above 100Oversold
Rate of change−24.1%Change over 10 sessionsBearish
ATR (14)$0.11Typical daily range, 9.1% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for HIND

What happened before

See how HIND did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow HIND usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How HIND has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2021.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for HINDHow many large options trades hit HIND, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

HIND Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Neutral
Strongly bearishNeutralStrongly bullish
  • ▼4 buying vs 5 selling
  • ●Held by funds -0.3 pts
  • ▲Funds holding +1
  • ▼Superinvestors: 0 added, 1 cut
  • ●Put/call not meaningful
Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding1312+8.3%
In funds' top 1000–
Held by funds1.7%2.0%−0.3 pts
New / increased1 / 34 / 2−33.3%
Reduced / sold out4 / 11 / 1+150.0%
Put/call ratio–––
SuperinvestorsKen GriffinSold out
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See HIND institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether HIND is in one of them and how their past HIND trades turned out.

HIND in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered HIND in an article yet. Here's the latest on the wider market.

About Vyome Holdings

Vyome is a clinical stage specialty pharmaceutical company developing treatments for immune inflammatory and rare diseases. Its lead program is a topical gel for symptoms of malignant fungating wounds in advanced cancer. Its other development programs target uveitis, an eye condition, and moderate to severe acne, and none of its candidates is approved for sale. The company also sells dandruff lotion and shampoo, both antifungal products, in India through a licensing partner, Sun Pharma. It is based in San Clemente, California, with operations in Massachusetts, New Jersey and New Delhi, India.

Headquarters
San Clemente, CA